SEC Form 4 · accession 0001127602-16-045021
CONMED Corp · CNMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark D Snyder
Officer — EVP Mfg. Ops & Business System
Period of report
Mar 3, 2016
Accepted (ET)
Mar 4, 2016 · 12:43 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000816956
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 3, 2016 | M | 6,000 | $19.26 | A | 20,060 | D | |
| Common Stock | Mar 3, 2016 | F | 3,879 | $39.99 | D | 16,181 | D | |
| Common Stock | Mar 3, 2016 | M | 4,000 | $26.09 | A | 20,181 | D | |
| Common Stock | Mar 3, 2016 | F | 2,979 | $39.99 | D | 17,202 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sars (Stock Appreciation Rights)F1 | $19.26 | Mar 3, 2016 | M | 6,000 | D | — | Jun 1, 2020 | Common Stock | 6,000 | 0 | D |
| Sars (Stock Appreciation Rights)F1 | $26.09 | Mar 3, 2016 | M | 4,000 | D | — | Jun 1, 2022 | Common Stock | 4,000 | 4,000 | D |
Explanation of responses
- F1The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.